Abstract
Immunomodulators are biomolecules that are recognized for their characteristics to stimulate or suppress the adaptive or innate immunity. These agents modify the immune response by either enhancing (immunostimulators) or suppressing (immunosuppressants) the expression of inflammatory mediators such as cytokines and chemokines that activate immune cells. Withania somnifera (WS) is an ancient ayurvedic herb popularly known as “Ashwagandha” in India in Sanskrit and “winter cherry” outside India in English that has been used in indigenous medicines for over 3500 years or more, owing to its inexhaustible therapeutic value. Studies have shown a wide range of therapeutic applications associated with WS such as antibacterial, anti-inflammatory, antioxidant, anti-stress, antitumor, and anxiolytic, along with its protective role in numerous other ailments like cardiovascular, epilepsy, arthritis, diabetes, and depression. WS has also been recognized for its neuroprotective role in a number of degenerative conditions like Parkinson’s, Huntington’s, and most importantly Alzheimer’s disease. In today’s global scenario, the problem of infertility in males and disturbed sexual behavior in females is commonly observed. Withania has been shown to cure disorders related to reproductive system across countries with acceptable results. Currently, there is a drastic universal demand for development of herbal therapies effective for these ailments to minimize the side effects arising from chemotherapies. An overview of introduction and immunomodulatory role of Withania somnifera will be presented here with special focus on the mechanistic insights into the therapeutic effect of WS in treating Alzheimer’s and infertility problem. This chapter will also describe the latest attempts in biotechnological production of withanolides.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aalinkeel R, Hu Z, Nair BB, Sykes DE, Reynolds JL, Mahajan SD, Schwartz SA (2010) Genomic analysis highlights the role of the JAK-STAT signaling in the anti-proliferative effects of dietary flavonoid-'Ashwagandha' in prostate cancer cells. Evid Based Complement Alternat Med 7:177–187
Ahlawat S, Saxena P, Ali A, Abdin MZ (2015) Piriformospora indica elicitation of withaferin a biosynthesis and biomass accumulation in cell suspension cultures of Withania Somnifera. Symbioisis 69:37–46
Akram M, Nawaz A (2017) Effects of medicinal plants on Alzheimer's disease and memory deficits. Neural Regen Res 12:660–670
Apostolova LG (2016) Alzheimer disease. Continuum (Minneap Minn) 22:419–434
Bhandari C (1970) Ashwagandha(Withania Somnifera) ‘ Vanaoshadhi Chandroday” (An encyclopedia of Indian Herbs) Vol. 1 series of Varanasi Vidyavilas Press, Varanasi, pp. 96–97
Bonilla DA, Moreno Y, Gho C, Petro JL, Odriozola-Martínez A, Kreider RB (2021) Effects of ashwagandha (Withania somnifera) on physical performance: systematic review and Bayesian meta-analysis. J Funct Morphol Kinesiol 6:20
Cai Z, Kastell A, Knorr D, Smetanska I (2012) EXUDATION: an expanding technique for continuous production and release of secondary metabolites from plant cell suspension and hairy root cultures. Plant Cell Rep 31(3):461–477
Chandrasekhar K, Kapoor J, Anishetty S (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 34:255–262
Changhadi GS (1938) Ashwagandharishta- Ras Tantra Saar and Sidhyaprayog Sangrah. Krishna-Gopal Ayurveda Bhawan (Dharmarth Trust), Nagpur, 743–744
Ciddi V (2006) Withaferin a from cell cultures of Withania Somnifera. Indian J Pharma Sci 68:490–492
Davis L, Kuttan G (2000) Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193–200
Davis L, Kuttan G (2002) Effect of Withania somnifera on cell mediated immune responses in mice. J Exp Clin Cancer Res 21:585–590
Dhuley JN (1997) Effect of some Indian herbs on macrophage functions in ochratoxin A treated mice. J Ethnopharmacol 58:15–20
Dimpfel W, Schombert L, Keolinger-Dimpfel IK & Pannosian A (2020) Effects of an adaptogenic extract on electrical activity of the brain in elderly subjects with mild cognitive impairment: a randomized, double-blind, placebo-controlled, two-armed cross-over study. Pharmaceuticals (Basel), 13
Dubey S, Yoon H, Cohen MS, Nagarkatti P, NagarkattI M, Karan D (2018) Withaferin A associated differential regulation of inflammatory cytokines. Front Immunol 9:195
Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S (2019) Withania Somnifera (Ashwagandha) and withaferin a: potential in integrative oncology. Int J Mol Sci 20:5310
Eckert GP (2010) Traditional used plants against cognitive decline and Alzheimer disease. Front Pharmacol 1:138
Fan L, Mao C, Hu X, Zhang S, Yang Z, Hu Z, Sun H, Fan Y, Dong Y, Yang J, Shi C, Xu Y (2019) New insights into the pathogenesis of Alzheimer's disease. Front Neurol 10:1312
Gambhir L, Checker R, Sharma D, Thoh M, Patil A, Degani M, Gota V, Sandur SK (2015) Thiol dependent NF-kappaB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A. Toxicol Appl Pharmacol 289:297–312
Gautam A, Wadhwa R, Thakur MK (2016) Assessment of cholinergic properties of Ashwagandha leaf-extract in the amnesic mouse brain. Ann Neurosci 23:68–75
Gautam M, Diwanay SS, Gairola S, Shinde YS, Jadhav SS, Patwardhan BK (2004) Immune response modulation to DPT vaccine by aqueous extract of Withania somnifera in experimental system. Int J Immunopharmacol 4:841–849
Govardhan S (1938) Ashwagandharishta-Rastantra Sar Evam Sidhyaprayog Sangrah. Krishna-Gopal Ayurveda Bhawan (Dharmarth Trust), Nagpur, pp 743–744
Gupta M, Kaur G (2019) Withania somnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation. BMC Complement Altern Med 19:217
Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020, vol 2. Cold Spring Harb Perspect Biol Med, p a011585
Ichikaw AH, Takada Y, Shishodia S, Jayaprakasham B, Nair MG, Aggarwal BB (2006) Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression. Mol Cancer Ther 5:1434–1445
Ilayperuma I, Ramasooriya WD, Weerasooriya TR (2002) Effect of Withania somnifera root extract on the s sexual behavior of male rats. Asian J Androl 4(4):295–298
Iuvone T, Esposito G, Capasso F, Izzo AA (2003) Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci 72:1617–1625
Jayaprakasham B, Padmanabhan K, Nair MG (2010) Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Phytother Res 24:859–863
Kaur T, Singh H, Mishra R, Manchanda S, Gupta M, SainiI V, Sharma A, Kaur G (2017) Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats. Mol Cell Biochem 427:91–101
Kelgane SB, Salve J, Sampara P, Debnath K (2020) Efficacy and tolerability of ashwagandha root extract in the elderly for improvement of general Well-being and sleep: a prospective, randomized, double-blind, placebo-controlled study. Cureus 12:e7083
Keuboyama T, Tohda C, Komatsu K (2014) Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull 37:892–897
Khan S, Malik F, Suri KA, Singh J (2009) Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity. Vaccine 27:6080–6087
Konar A, Gupta R, Shukla RK, Maloney B, Khanna VK, Wadhwa R, Lahiri DK, Thakur MK (2019) M1 muscarinic receptor is a key target of neuroprotection, neuroregeneration and memory recovery by i-Extract from Withania Somnifera. Sci Rep 9:13990
Krauss C (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25(2):271–278
Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961–971
Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K (2002) Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport 13:1715–1720
Kumar S, Harris RJ, Seal CJ, Okello EJ (2012) An aqueous extract of Withania Somnifera root inhibits amyloid beta fibril formation in vitro. Phytother Res 26:113–117
Kurapati KR, AtluriI VS, Sammikannu T, Nair MP (2013) Ashwagandha (Withania somnifera) reverses beta-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e77624
Lopresti AL, Smith SJ, Malvi H, Kodgule R (2019) An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore) 98:17186
Ma Y, Yang MW, Li XW, Yue JW, Chen JZ, Yang MW, Huang X, Zhu LL, Hong FF, Yang SL (2019) Therapeutic effects of natural drugs on Alzheimer's disease. Front Pharmacol 10:1355
Mahima RA, Deb R, Latheef SK, Abdul Samad H, Tiwari R, Verma AK, Kumar A, Dhama K (2012) Immunomodulatory and therapeutic potentials og herbal traditional/indigenous and ethno veterinary medicines. Pak J Biol Sci 15:754–774
Mandlik Ingawale DS, Namdeo AG (2020) Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. J Diet Suppl:1–44
Martorana F, Guidotti G, Brambilla L, Rossi D (2015) Withaferin A inhibits nuclear factor-kappaB-dependent pro-inflammatory and stress response pathways in the astrocytes. Neural Plast 2015:381964
Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH et al (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348:2379–2385
Mishra L, Singh BB, Dagenias S (2000a) Scientific basis for the therapeutic use of Withania Somnifera (Ashwagandha): a review. Altern Med Rev 5(4):334–336
Mishra LC, Singh BB, Dagenais S (2000b) Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5:334–346
Mohanty IR, Arya DS, Gupta SK (2008) Withania Somnifera provides cardioprotection and attenuates ischemia-reperfusion induced apoptosis. Clin Nutr 27:635–642
Mulabagal V, Subbaraju GV, Rao CV, Sivaramakrishna C, Dewitt DL, Holmes D, Sung G, Aggarawal BB, Tsay HS, Nair MG (2009) Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res 23:987–992
Muralikrishnan G, Dinda AK, Shakeel F (2010) Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Invest 39:688–698
Nagella P, Murthy HN (2010) Effect of macro elements and nitrogen source on biomass accumulation of and Withanolide A production from cell suspension cultures of Withania Somnifera(L.) Dunal. Plant Cell Tissue Cult Organ Cult 104:119–124
Nasimi R, Zomossdi A et al, (2018) Effects of Withania Somnifera on reproductive system: a systematic review of the available Evidence. ID 4076430, 17 pages
Ng QX, Loke W, Foo NX, Tan WJ, Chan HW, Lim DY, Yeo WS (2020) A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction. Phytother Res 34:583–590
Palliyaguru DL, Singh SV, Kensler TW (2016) Withania somnifera: from prevention to treatment of cancer. Mol Nutr Food Res 60:1342–1353
Patil RR, Vora SR, Pillai MM (2012) Protective effect of spermatogenic activity of Withania somnifera (Ashwagandha) in galactus stressed mice. Anim Biol Res 3(8):4169–4165
Plunkett ML, Sanders ME, Selvaraj P, Dustin ML, Springer TA (1987) Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3). J Exp Med 165:664–676
Pratte MA, NanavatiI KB, Young V, Morley CP (2014) An alternative treatment for anxiety: a systematic review of human trial results reported for the ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med 20:901–908
Praveen N, Murthy HN (2010) Production of Withanolide-A form adventitious root culture of Withania Somnifera. Acta Physiologiae Plantarum 32(5):1017–1022
Praveen N, Murthy HN (2012) Withanolide A production from Withania Somnifera hairy root cultures with improved growth by altering the concentrations of macro elements and nitrogen sources in the medium. Acta Physioogiae Plantarum 35:811–816
Rao RV, Descamps O, John V, Bredesen DE (2012) Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimers Res Ther 4:22
Sharma AK, Basu I, Singh S (2018) Efficacy and safety of Ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med 24:243–248
Singh N, Bhalla M, de Jager P, Gilca M (2011) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 8(5 Suppl):208–213
Singham N, Bhalla P, Jager MG (2011) An overview on ashwagandha: a Rasayan (rejuvenator) of ayurveda. Afr J Tradit Complement Altern Med 8(5):208–213
Sivanandhan G, Arun M, Mayavan S, Rajesh M, Mariashibu TS, Manickavasagam M, Selvaraj N, Ganapathi A (2012) Chitosan enhances withanolides production in adventitious root cultures of Withania somnifera (L.) Dunal. Ind Crop Prod 37(1)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Ethics declarations
The author declares that there are no competing interests.
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saini, D., Srivastava, M., Vaid, S., Kesharwani, V. (2022). Therapeutic Effects of Withania somnifera: An Overview with Special Focus on Alzheimer’s Disease and Infertility among Youth. In: Kesharwani, R.K., Keservani, R.K., Sharma, A.K. (eds) Nutraceuticals and Functional Foods in Immunomodulators. Springer, Singapore. https://doi.org/10.1007/978-981-19-2507-8_14
Download citation
DOI: https://doi.org/10.1007/978-981-19-2507-8_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-2506-1
Online ISBN: 978-981-19-2507-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)